Clinical

Dataset Information

0

Phase I exploratory clinical study of CD276-targeted chimeric antigen receptor T cells for the treatment of solid tumors


ABSTRACT: Interventions: experimental group:CD276-targeted chimeric antigen receptor T cells Primary outcome(s): SAE rate Study Design: Single arm

DISEASE(S): Solid Tumors Mainly Include But Are Not Limited To Advanced Lung Cancer, Esophageal Cancer And Colorectal Cancer

PROVIDER: 2703905 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJNA727540 | ENA
| PRJNA916209 | ENA
| 2317628 | ecrin-mdr-crc
| PRJNA448188 | ENA
| PRJNA448192 | ENA
| PRJNA437645 | ENA
| PRJNA1009859 | ENA
2018-07-31 | GSE111641 | GEO
2018-07-31 | GSE112566 | GEO
2015-01-14 | GSE64914 | GEO